ESBL

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\ESBL.php on line 2
ESBL

LE WE PMID CA

ESBL

845

ESBL

Acinetobacter baumannii

AmpC

Antibiotics (Resistance)

Carbapenemase

ESBL

Pseudomonas aeruginosa

Urinary tract infection

2003 1	Recent developments in beta lactamases and extended spectrum beta lactamases. [14630759] BMJ 327(7425): 1209-13 (2003)
2004 2	Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. [15561828] Antimicrob Agents Chemother 48(12): 4574-81 (2004)
2004 3	Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. [14693512] Antimicrob Agents Chemother 48(1): 1-14 (2004)
2003 4	Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. [12878494] Antimicrob Agents Chemother 47(8): 2385-92 (2003)
1995 5	Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure. [8592985] Antimicrob Agents Chemother 39(12): 2593-601 (1995)
1991 6	More extended-spectrum beta-lactamases. [1952834] Antimicrob Agents Chemother 35(9): 1697-704 (1991)
1989 7	Extended-spectrum beta-lactamases. [2679367] Antimicrob Agents Chemother 33(8): 1131-6 (1989)
2007 8	Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. [17848376] J Antimicrob Chemother 60(5): 913-20 (2007)
2007 9	CTX-M: changing the face of ESBLs in Europe. [17158117] J Antimicrob Chemother 59(2): 165-74 (2007)
2005 10	CTX-M: changing the face of ESBLs in the UK. [16006451] J Antimicrob Chemother 56(3): 451-4 (2005)
2005 11	Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. [15917288] J Antimicrob Chemother 56(1): 52-9 (2005)
1998 12	Extended-spectrum beta-lactamases: the role of inhibitors in therapy. [9818738] J Antimicrob Chemother 42(4): 415-7 (1998)
2005 13	Extended-spectrum beta-lactamases: a clinical update. [16223952] Clin Microbiol Rev 18(4): 657-86 (2005)
2001 14	Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. [11585791] Clin Microbiol Rev 14(4): 933-51, table of contents (2001)
2008 15	Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. [18154548] Clin Microbiol Infect 14 Suppl 1(-): 198-202 (2008)
2008 16	Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers. [18154546] Clin Microbiol Infect 14 Suppl 1(-): 189-93 (2008)
2008 17	Control of infections due to extended-spectrum beta-lactamase-producing organisms in hospitals and the community. [18154536] Clin Microbiol Infect 14 Suppl 1(-): 124-33 (2008)
2008 18	Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. [18154532] Clin Microbiol Infect 14 Suppl 1(-): 90-103 (2008)
2008 19	Extended-spectrum beta-lactamases: structure and kinetic mechanism. [18154529] Clin Microbiol Infect 14 Suppl 1(-): 63-74 (2008)
2008 20	IRT and CMT beta-lactamases and inhibitor resistance. [18154528] Clin Microbiol Infect 14 Suppl 1(-): 53-62 (2008)
2008 21	Minor extended-spectrum beta-lactamases. [18154527] Clin Microbiol Infect 14 Suppl 1(-): 42-52 (2008)
2008 22	The spread of CTX-M-type extended-spectrum beta-lactamases. [18154526] Clin Microbiol Infect 14 Suppl 1(-): 33-41 (2008)
2008 23	Evolution of extended-spectrum beta-lactamases by mutation. [18154525] Clin Microbiol Infect 14 Suppl 1(-): 11-32 (2008)
2008 24	Defining an extended-spectrum beta-lactamase. [18154524] Clin Microbiol Infect 14 Suppl 1(-): 3-10 (2008)
2005 25	Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. [16209701] Clin Microbiol Infect 11 Suppl 6(-): 10-7 (2005)
2005 26	Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). [15953019] Clin Microbiol Infect 11 Suppl 4(-): 1-16 (2005)
2001 27	Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. [11737084] Clin Microbiol Infect 7(11): 597-608 (2001)
2005 28	Extended-spectrum beta-lactamases: the end of cephalosporins? [15909470] Isr Med Assoc J 7(5): 336-8 (2005)
2011 29	Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. [21364117] Mayo Clin Proc 86(3): 250-9 (2011)
2006 30	Extended-spectrum beta-lactamases and clinical outcomes: current data. [16544267] Clin Infect Dis 42 Suppl 4(-): S164-72 (2006)
2006 31	Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. [16544266] Clin Infect Dis 42 Suppl 4(-): S153-63 (2006)
2009 32	Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. [19231979] Clin Infect Dis 48(7): 916-21 (2009)
2008 33	ESBLs detection in clinical microbiology: why & how? [18577783] Indian J Med Res 127(4): 297-300 (2008)
2010 34	Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. [20876625] J Antimicrob Chemother 65 Suppl 3(-): iii25-33 (2010)
2008 35	Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy. [19127103] Korean J Lab Med 28(6): 401-12 (2008)
2011 36	Laboratory detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae: evaluation of two screening agar plates and two confirmation techniques. [21123527] J Clin Microbiol 49(2): 519-22 (2011)
2004 37	Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae. [14715768] J Clin Microbiol 42(1): 294-8 (2004)
2010 38	Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues. [20181902] J Clin Microbiol 48(4): 1019-25 (2010)
2006 39	VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. [16965700] Emerg Infect Dis 12(8): 1214-22 (2006)
2010 40	Extended-spectrum β-lactamases in Gram Negative Bacteria. [20927289] J Glob Infect Dis 2(3): 263-74 (2010)
2007 41	Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains. [17802921] New Microbiol 30(3): 332-9 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\ESBL.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\ESBL.php on line 92